NBT Bancorp (NBTB) news
Recent news
First Tracks Biotherapeutics shares rise 13.3% premarket after positive results from celiac disease drug trial
First Tracks Biotherapeutics Inc. (NASDAQ: FTBT) reported a 13.3% increase in premarket trading on October 12, 2026, following the release of positive clinical trial results . The company announced that the drug demonstrated a favorable safety profile and showed measurable efficacy in reducing…
AInvest Wire · 4h agoKimberly A. Boynton named to NBT board of directors
Kimberly A. Boynton has been appointed to the board of directors of NBT Bancorp Inc. (NBT), a regional bank holding company headquartered in New York. The appointment was announced as part of the company’s ongoing efforts to strengthen its governance and leadership structure. Boynton brings…
AInvest Wire · Sep 21, 2026NBT Bancorp Inc: Stephens cuts to equal-weight from overweight; raises target price to $55 from $52
AInvest Wire · Jul 31, 2026NBT Bancorp 2Q loan-loss provision $6.1M, est. $5.83M
AInvest Wire · Jul 27, 2026NBT Bancorp 2Q operating EPS $1.01, estimated $1.02
AInvest Wire · Jul 27, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.